Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
These two are at very different stages of the clinical trials process.
Mindfully Curated
These two are at very different stages of the clinical trials process.
Your paycheck could work to your advantage beyond the wages it provides you with.
The potential for lower interest rates has been good for retailers.
The year has just started, but there are some excellent opportunities for investors with cash on the sidelines.
According to Bitcoin bull and MicroStrategy CEO Michael Saylor, Bitcoin’s unique properties make it a superior store of value over the long haul.
Investors took a brighter outlook on the company’s prospects for 2024.
Nvidia stock continues to dominate thanks to its massive lead in the artificial intelligence market.
If Shiba Inu were to reach $1 per coin, a $100 investment at today’s prices would turn into roughly $10 million.
The Chinese e-commerce stock has struggled in recent years. Can it finally mount a turnaround?
Intel may be about to tap its piggy bank again as it gears up for massive chip manufacturing spending.
There’s a reason this Fool is putting money into each one.
Cathie Wood may prefer innovative growth stocks, but the popular investment manager owns several dividend stocks.
These companies have the potential to justify their expensive valuations.
These four names span different sectors, but all underperformed in 2023. Is it time to be a contrarian and pick up bargains on the discount aisle?